Concert Pharmaceuticals Inc

NASDAQ:CNCE   3:59:52 PM EDT
5.03
+0.35 (+7.48%)
Earnings Announcements

Concert Pharmaceuticals Reports First Quarter 2022 Financial Results

Published: 05/05/2022 11:19 GMT
Concert Pharmaceuticals Inc (CNCE) - Concert Pharmaceuticals Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $1.03.
Concert Pharmaceuticals - Expects Its Current Cash, Cash Equivalents and Investments to Fund Company Into Q4 of 2022.
Qtrly Loss per Share $1.03.
Q1 Earnings per Share View $-0.91 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.89

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.83

More details on our Analysts Page.